Question 1
In preclinical vaccine development, which study is primarily used to assess immunogenicity and protective efficacy before human trials?
Question 2
How is vaccine efficacy defined in randomized controlled trials?
Question 3
Which vaccine platform uses a nonpathogenic virus to deliver genes encoding the antigen into host cells?
Question 4
What is the primary objective of Phase II vaccine trials?
Question 5
An immunobridging study is conducted to:
